When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
SURF - Surface Oncology launches early-stage study of cancer candidate SRF388
Surface Oncology Inc.
Thinly traded nano cap Surface Oncology (SURF+4.6%) is up on below-average volume on the heels of its announcement that it has initiated a Phase 1 clinical trial evaluating escalating doses of interleukin-27 (IL-27) inhibitor SRF388 in patients with advanced solid tumors.
More news on: Surface Oncology, Inc., Healthcare stocks news, Stocks on the move,